JP2018201345A - Composition containing liver hydrolyzate and houttuynia cordata extract - Google Patents
Composition containing liver hydrolyzate and houttuynia cordata extract Download PDFInfo
- Publication number
- JP2018201345A JP2018201345A JP2017106825A JP2017106825A JP2018201345A JP 2018201345 A JP2018201345 A JP 2018201345A JP 2017106825 A JP2017106825 A JP 2017106825A JP 2017106825 A JP2017106825 A JP 2017106825A JP 2018201345 A JP2018201345 A JP 2018201345A
- Authority
- JP
- Japan
- Prior art keywords
- liver hydrolyzate
- extract
- liver
- hydrolyzate
- parts
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 210000004185 liver Anatomy 0.000 title claims abstract description 106
- 239000000203 mixture Substances 0.000 title claims abstract description 53
- 239000009141 Houttuynia cordata plant extract Substances 0.000 title 1
- 239000000284 extract Substances 0.000 claims abstract description 59
- 239000007788 liquid Substances 0.000 claims abstract description 42
- 240000000691 Houttuynia cordata Species 0.000 claims abstract description 41
- 235000013719 Houttuynia cordata Nutrition 0.000 claims abstract description 41
- 235000019640 taste Nutrition 0.000 claims abstract description 7
- 235000013361 beverage Nutrition 0.000 claims description 28
- 238000002156 mixing Methods 0.000 claims description 11
- 239000002994 raw material Substances 0.000 claims description 10
- 239000004480 active ingredient Substances 0.000 claims description 5
- 238000004519 manufacturing process Methods 0.000 claims description 5
- 238000000034 method Methods 0.000 claims description 5
- 239000003814 drug Substances 0.000 abstract description 10
- 206010013911 Dysgeusia Diseases 0.000 description 16
- 230000000052 comparative effect Effects 0.000 description 15
- 238000011156 evaluation Methods 0.000 description 13
- 230000001953 sensory effect Effects 0.000 description 13
- 239000000796 flavoring agent Substances 0.000 description 11
- 235000019634 flavors Nutrition 0.000 description 11
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 10
- 235000013372 meat Nutrition 0.000 description 9
- 229940079593 drug Drugs 0.000 description 8
- 235000020240 turmeric extract Nutrition 0.000 description 7
- KRKNYBCHXYNGOX-UHFFFAOYSA-N citric acid Chemical compound OC(=O)CC(O)(C(O)=O)CC(O)=O KRKNYBCHXYNGOX-UHFFFAOYSA-N 0.000 description 6
- 229940052016 turmeric extract Drugs 0.000 description 6
- 239000008513 turmeric extract Substances 0.000 description 6
- 238000013329 compounding Methods 0.000 description 5
- 230000000694 effects Effects 0.000 description 5
- GVJHHUAWPYXKBD-UHFFFAOYSA-N (±)-α-Tocopherol Chemical compound OC1=C(C)C(C)=C2OC(CCCC(C)CCCC(C)CCCC(C)C)(C)CCC2=C1C GVJHHUAWPYXKBD-UHFFFAOYSA-N 0.000 description 4
- CIWBSHSKHKDKBQ-JLAZNSOCSA-N Ascorbic acid Chemical compound OC[C@H](O)[C@H]1OC(=O)C(O)=C1O CIWBSHSKHKDKBQ-JLAZNSOCSA-N 0.000 description 4
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
- 239000008186 active pharmaceutical agent Substances 0.000 description 4
- -1 cyclic oligosaccharides Chemical class 0.000 description 4
- 229940088679 drug related substance Drugs 0.000 description 4
- 239000000047 product Substances 0.000 description 4
- 235000019583 umami taste Nutrition 0.000 description 4
- 240000000560 Citrus x paradisi Species 0.000 description 3
- 244000163122 Curcuma domestica Species 0.000 description 3
- 235000003392 Curcuma domestica Nutrition 0.000 description 3
- 239000003795 chemical substances by application Substances 0.000 description 3
- 235000003373 curcuma longa Nutrition 0.000 description 3
- 239000000049 pigment Substances 0.000 description 3
- 235000013976 turmeric Nutrition 0.000 description 3
- IKHGUXGNUITLKF-UHFFFAOYSA-N Acetaldehyde Chemical compound CC=O IKHGUXGNUITLKF-UHFFFAOYSA-N 0.000 description 2
- 229920001817 Agar Polymers 0.000 description 2
- 241000283690 Bos taurus Species 0.000 description 2
- 229920002134 Carboxymethyl cellulose Polymers 0.000 description 2
- ZZZCUOFIHGPKAK-UHFFFAOYSA-N D-erythro-ascorbic acid Natural products OCC1OC(=O)C(O)=C1O ZZZCUOFIHGPKAK-UHFFFAOYSA-N 0.000 description 2
- RGHNJXZEOKUKBD-SQOUGZDYSA-N D-gluconic acid Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C(O)=O RGHNJXZEOKUKBD-SQOUGZDYSA-N 0.000 description 2
- 206010019133 Hangover Diseases 0.000 description 2
- NBIIXXVUZAFLBC-UHFFFAOYSA-N Phosphoric acid Chemical compound OP(O)(O)=O NBIIXXVUZAFLBC-UHFFFAOYSA-N 0.000 description 2
- 229930003268 Vitamin C Natural products 0.000 description 2
- 229930003427 Vitamin E Natural products 0.000 description 2
- 230000009471 action Effects 0.000 description 2
- 239000008272 agar Substances 0.000 description 2
- 235000010419 agar Nutrition 0.000 description 2
- 239000003963 antioxidant agent Substances 0.000 description 2
- 235000006708 antioxidants Nutrition 0.000 description 2
- 230000008901 benefit Effects 0.000 description 2
- 235000010948 carboxy methyl cellulose Nutrition 0.000 description 2
- 239000001768 carboxy methyl cellulose Substances 0.000 description 2
- 239000008112 carboxymethyl-cellulose Substances 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- 239000003995 emulsifying agent Substances 0.000 description 2
- 235000013305 food Nutrition 0.000 description 2
- 235000003599 food sweetener Nutrition 0.000 description 2
- WIGCFUFOHFEKBI-UHFFFAOYSA-N gamma-tocopherol Natural products CC(C)CCCC(C)CCCC(C)CCCC1CCC2C(C)C(O)C(C)C(C)C2O1 WIGCFUFOHFEKBI-UHFFFAOYSA-N 0.000 description 2
- 238000010438 heat treatment Methods 0.000 description 2
- JVTAAEKCZFNVCJ-UHFFFAOYSA-N lactic acid Chemical compound CC(O)C(O)=O JVTAAEKCZFNVCJ-UHFFFAOYSA-N 0.000 description 2
- 229940040511 liver extract Drugs 0.000 description 2
- 230000000873 masking effect Effects 0.000 description 2
- 229910052751 metal Inorganic materials 0.000 description 2
- 239000002184 metal Substances 0.000 description 2
- DNIAPMSPPWPWGF-UHFFFAOYSA-N monopropylene glycol Natural products CC(O)CO DNIAPMSPPWPWGF-UHFFFAOYSA-N 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 229920000139 polyethylene terephthalate Polymers 0.000 description 2
- 239000005020 polyethylene terephthalate Substances 0.000 description 2
- 239000000843 powder Substances 0.000 description 2
- 238000002360 preparation method Methods 0.000 description 2
- LXNHXLLTXMVWPM-UHFFFAOYSA-N pyridoxine Chemical compound CC1=NC=C(CO)C(CO)=C1O LXNHXLLTXMVWPM-UHFFFAOYSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 235000013599 spices Nutrition 0.000 description 2
- 235000000346 sugar Nutrition 0.000 description 2
- 239000003765 sweetening agent Substances 0.000 description 2
- 239000002562 thickening agent Substances 0.000 description 2
- 229930003231 vitamin Natural products 0.000 description 2
- 239000011782 vitamin Substances 0.000 description 2
- 235000013343 vitamin Nutrition 0.000 description 2
- 229940088594 vitamin Drugs 0.000 description 2
- 235000019154 vitamin C Nutrition 0.000 description 2
- 239000011718 vitamin C Substances 0.000 description 2
- 235000019165 vitamin E Nutrition 0.000 description 2
- 239000011709 vitamin E Substances 0.000 description 2
- 229940046009 vitamin E Drugs 0.000 description 2
- 239000003021 water soluble solvent Substances 0.000 description 2
- PFTAWBLQPZVEMU-DZGCQCFKSA-N (+)-catechin Chemical compound C1([C@H]2OC3=CC(O)=CC(O)=C3C[C@@H]2O)=CC=C(O)C(O)=C1 PFTAWBLQPZVEMU-DZGCQCFKSA-N 0.000 description 1
- BJEPYKJPYRNKOW-REOHCLBHSA-N (S)-malic acid Chemical compound OC(=O)[C@@H](O)CC(O)=O BJEPYKJPYRNKOW-REOHCLBHSA-N 0.000 description 1
- IIZPXYDJLKNOIY-JXPKJXOSSA-N 1-palmitoyl-2-arachidonoyl-sn-glycero-3-phosphocholine Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@H](COP([O-])(=O)OCC[N+](C)(C)C)OC(=O)CCC\C=C/C\C=C/C\C=C/C\C=C/CCCCC IIZPXYDJLKNOIY-JXPKJXOSSA-N 0.000 description 1
- 239000001606 7-[(2S,3R,4S,5S,6R)-4,5-dihydroxy-6-(hydroxymethyl)-3-[(2S,3R,4R,5R,6S)-3,4,5-trihydroxy-6-methyloxan-2-yl]oxyoxan-2-yl]oxy-5-hydroxy-2-(4-hydroxyphenyl)chroman-4-one Substances 0.000 description 1
- 244000215068 Acacia senegal Species 0.000 description 1
- WBZFUFAFFUEMEI-UHFFFAOYSA-M Acesulfame k Chemical compound [K+].CC1=CC(=O)[N-]S(=O)(=O)O1 WBZFUFAFFUEMEI-UHFFFAOYSA-M 0.000 description 1
- 108010011485 Aspartame Proteins 0.000 description 1
- JMGZEFIQIZZSBH-UHFFFAOYSA-N Bioquercetin Natural products CC1OC(OCC(O)C2OC(OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5)C(O)C2O)C(O)C(O)C1O JMGZEFIQIZZSBH-UHFFFAOYSA-N 0.000 description 1
- 206010006784 Burning sensation Diseases 0.000 description 1
- 241000207199 Citrus Species 0.000 description 1
- RGHNJXZEOKUKBD-UHFFFAOYSA-N D-gluconic acid Natural products OCC(O)C(O)C(O)C(O)C(O)=O RGHNJXZEOKUKBD-UHFFFAOYSA-N 0.000 description 1
- FEWJPZIEWOKRBE-JCYAYHJZSA-N Dextrotartaric acid Chemical compound OC(=O)[C@H](O)[C@@H](O)C(O)=O FEWJPZIEWOKRBE-JCYAYHJZSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 229930091371 Fructose Natural products 0.000 description 1
- 239000005715 Fructose Substances 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- 108010010803 Gelatin Proteins 0.000 description 1
- 229920002148 Gellan gum Polymers 0.000 description 1
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerol Natural products OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 1
- 235000010469 Glycine max Nutrition 0.000 description 1
- 229920002907 Guar gum Polymers 0.000 description 1
- 229920000084 Gum arabic Polymers 0.000 description 1
- 229920000569 Gum karaya Polymers 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- 229920000161 Locust bean gum Polymers 0.000 description 1
- 244000241838 Lycium barbarum Species 0.000 description 1
- 235000015459 Lycium barbarum Nutrition 0.000 description 1
- 235000015468 Lycium chinense Nutrition 0.000 description 1
- 241001465754 Metazoa Species 0.000 description 1
- 229920000168 Microcrystalline cellulose Polymers 0.000 description 1
- PVNIIMVLHYAWGP-UHFFFAOYSA-N Niacin Chemical compound OC(=O)C1=CC=CN=C1 PVNIIMVLHYAWGP-UHFFFAOYSA-N 0.000 description 1
- 102000035195 Peptidases Human genes 0.000 description 1
- 108091005804 Peptidases Proteins 0.000 description 1
- 108010009736 Protein Hydrolysates Proteins 0.000 description 1
- 229920002472 Starch Polymers 0.000 description 1
- 241000934878 Sterculia Species 0.000 description 1
- 229930182558 Sterol Natural products 0.000 description 1
- 244000228451 Stevia rebaudiana Species 0.000 description 1
- 239000004376 Sucralose Substances 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 241000282887 Suidae Species 0.000 description 1
- 240000004584 Tamarindus indica Species 0.000 description 1
- 235000004298 Tamarindus indica Nutrition 0.000 description 1
- FEWJPZIEWOKRBE-UHFFFAOYSA-N Tartaric acid Natural products [H+].[H+].[O-]C(=O)C(O)C(O)C([O-])=O FEWJPZIEWOKRBE-UHFFFAOYSA-N 0.000 description 1
- 229930003451 Vitamin B1 Natural products 0.000 description 1
- 206010000059 abdominal discomfort Diseases 0.000 description 1
- 235000010489 acacia gum Nutrition 0.000 description 1
- 239000000205 acacia gum Substances 0.000 description 1
- 235000010358 acesulfame potassium Nutrition 0.000 description 1
- 229960004998 acesulfame potassium Drugs 0.000 description 1
- 239000000619 acesulfame-K Substances 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 150000007513 acids Chemical class 0.000 description 1
- GZCGUPFRVQAUEE-SLPGGIOYSA-N aldehydo-D-glucose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O GZCGUPFRVQAUEE-SLPGGIOYSA-N 0.000 description 1
- 235000010443 alginic acid Nutrition 0.000 description 1
- 239000000783 alginic acid Substances 0.000 description 1
- 229920000615 alginic acid Polymers 0.000 description 1
- 229960001126 alginic acid Drugs 0.000 description 1
- BJEPYKJPYRNKOW-UHFFFAOYSA-N alpha-hydroxysuccinic acid Natural products OC(=O)C(O)CC(O)=O BJEPYKJPYRNKOW-UHFFFAOYSA-N 0.000 description 1
- 229910000147 aluminium phosphate Inorganic materials 0.000 description 1
- 208000007502 anemia Diseases 0.000 description 1
- 230000003078 antioxidant effect Effects 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 239000000605 aspartame Substances 0.000 description 1
- 235000010357 aspartame Nutrition 0.000 description 1
- IAOZJIPTCAWIRG-QWRGUYRKSA-N aspartame Chemical compound OC(=O)C[C@H](N)C(=O)N[C@H](C(=O)OC)CC1=CC=CC=C1 IAOZJIPTCAWIRG-QWRGUYRKSA-N 0.000 description 1
- 229960003438 aspartame Drugs 0.000 description 1
- 235000019658 bitter taste Nutrition 0.000 description 1
- 235000014171 carbonated beverage Nutrition 0.000 description 1
- BVKZGUZCCUSVTD-UHFFFAOYSA-N carbonic acid Chemical compound OC(O)=O BVKZGUZCCUSVTD-UHFFFAOYSA-N 0.000 description 1
- 235000010418 carrageenan Nutrition 0.000 description 1
- 239000000679 carrageenan Substances 0.000 description 1
- 229920001525 carrageenan Polymers 0.000 description 1
- 229940113118 carrageenan Drugs 0.000 description 1
- ADRVNXBAWSRFAJ-UHFFFAOYSA-N catechin Natural products OC1Cc2cc(O)cc(O)c2OC1c3ccc(O)c(O)c3 ADRVNXBAWSRFAJ-UHFFFAOYSA-N 0.000 description 1
- 235000005487 catechin Nutrition 0.000 description 1
- 235000010980 cellulose Nutrition 0.000 description 1
- 239000001913 cellulose Substances 0.000 description 1
- 229920002678 cellulose Polymers 0.000 description 1
- 239000003610 charcoal Substances 0.000 description 1
- 229950001002 cianidanol Drugs 0.000 description 1
- 235000020971 citrus fruits Nutrition 0.000 description 1
- 238000000354 decomposition reaction Methods 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- 235000015872 dietary supplement Nutrition 0.000 description 1
- 102000038379 digestive enzymes Human genes 0.000 description 1
- 108091007734 digestive enzymes Proteins 0.000 description 1
- XMXOIHIZTOVVFB-JIZZDEOASA-L disodium;(2s)-2-aminobutanedioate Chemical compound [Na+].[Na+].[O-]C(=O)[C@@H](N)CC([O-])=O XMXOIHIZTOVVFB-JIZZDEOASA-L 0.000 description 1
- IVTMALDHFAHOGL-UHFFFAOYSA-N eriodictyol 7-O-rutinoside Natural products OC1C(O)C(O)C(C)OC1OCC1C(O)C(O)C(O)C(OC=2C=C3C(C(C(O)=C(O3)C=3C=C(O)C(O)=CC=3)=O)=C(O)C=2)O1 IVTMALDHFAHOGL-UHFFFAOYSA-N 0.000 description 1
- 238000000605 extraction Methods 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 238000011049 filling Methods 0.000 description 1
- 239000011888 foil Substances 0.000 description 1
- 238000009472 formulation Methods 0.000 description 1
- 239000003205 fragrance Substances 0.000 description 1
- 239000008273 gelatin Substances 0.000 description 1
- 229920000159 gelatin Polymers 0.000 description 1
- 235000019322 gelatine Nutrition 0.000 description 1
- 235000011852 gelatine desserts Nutrition 0.000 description 1
- 235000010492 gellan gum Nutrition 0.000 description 1
- 239000000216 gellan gum Substances 0.000 description 1
- 239000003349 gelling agent Substances 0.000 description 1
- 239000011521 glass Substances 0.000 description 1
- 239000000174 gluconic acid Substances 0.000 description 1
- 235000012208 gluconic acid Nutrition 0.000 description 1
- 235000011187 glycerol Nutrition 0.000 description 1
- 235000010417 guar gum Nutrition 0.000 description 1
- 239000000665 guar gum Substances 0.000 description 1
- 229960002154 guar gum Drugs 0.000 description 1
- 229920000591 gum Polymers 0.000 description 1
- 241000411851 herbal medicine Species 0.000 description 1
- 239000008123 high-intensity sweetener Substances 0.000 description 1
- 235000012907 honey Nutrition 0.000 description 1
- 230000006872 improvement Effects 0.000 description 1
- 239000004615 ingredient Substances 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 235000015110 jellies Nutrition 0.000 description 1
- 239000008274 jelly Substances 0.000 description 1
- 235000010494 karaya gum Nutrition 0.000 description 1
- 239000000231 karaya gum Substances 0.000 description 1
- 229940039371 karaya gum Drugs 0.000 description 1
- 239000004310 lactic acid Substances 0.000 description 1
- 235000014655 lactic acid Nutrition 0.000 description 1
- 235000010445 lecithin Nutrition 0.000 description 1
- 239000000787 lecithin Substances 0.000 description 1
- 229940067606 lecithin Drugs 0.000 description 1
- 235000021056 liquid food Nutrition 0.000 description 1
- 230000003908 liver function Effects 0.000 description 1
- 235000010420 locust bean gum Nutrition 0.000 description 1
- 239000000711 locust bean gum Substances 0.000 description 1
- 239000001630 malic acid Substances 0.000 description 1
- 235000011090 malic acid Nutrition 0.000 description 1
- 230000004060 metabolic process Effects 0.000 description 1
- 235000019813 microcrystalline cellulose Nutrition 0.000 description 1
- 239000008108 microcrystalline cellulose Substances 0.000 description 1
- 229940016286 microcrystalline cellulose Drugs 0.000 description 1
- 239000012046 mixed solvent Substances 0.000 description 1
- DFPMSGMNTNDNHN-ZPHOTFPESA-N naringin Chemical compound O[C@@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@H]1O[C@H]1[C@H](OC=2C=C3O[C@@H](CC(=O)C3=C(O)C=2)C=2C=CC(O)=CC=2)O[C@H](CO)[C@@H](O)[C@@H]1O DFPMSGMNTNDNHN-ZPHOTFPESA-N 0.000 description 1
- 229940052490 naringin Drugs 0.000 description 1
- 229930019673 naringin Natural products 0.000 description 1
- 235000001968 nicotinic acid Nutrition 0.000 description 1
- 239000011664 nicotinic acid Substances 0.000 description 1
- 229960003512 nicotinic acid Drugs 0.000 description 1
- 235000013615 non-nutritive sweetener Nutrition 0.000 description 1
- 235000016709 nutrition Nutrition 0.000 description 1
- 229920001542 oligosaccharide Polymers 0.000 description 1
- 210000000056 organ Anatomy 0.000 description 1
- 235000019629 palatability Nutrition 0.000 description 1
- 235000010987 pectin Nutrition 0.000 description 1
- 239000001814 pectin Substances 0.000 description 1
- 229920001277 pectin Polymers 0.000 description 1
- 239000008194 pharmaceutical composition Substances 0.000 description 1
- 235000011007 phosphoric acid Nutrition 0.000 description 1
- 239000002985 plastic film Substances 0.000 description 1
- 229920006255 plastic film Polymers 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 230000008569 process Effects 0.000 description 1
- 230000001737 promoting effect Effects 0.000 description 1
- RADKZDMFGJYCBB-UHFFFAOYSA-N pyridoxal hydrochloride Natural products CC1=NC=C(CO)C(C=O)=C1O RADKZDMFGJYCBB-UHFFFAOYSA-N 0.000 description 1
- FDRQPMVGJOQVTL-UHFFFAOYSA-N quercetin rutinoside Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 FDRQPMVGJOQVTL-UHFFFAOYSA-N 0.000 description 1
- 239000001397 quillaja saponaria molina bark Substances 0.000 description 1
- HELXLJCILKEWJH-NCGAPWICSA-N rebaudioside A Chemical compound O([C@H]1[C@H](O)[C@@H](CO)O[C@H]([C@@H]1O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)O[C@]12C(=C)C[C@@]3(C1)CC[C@@H]1[C@@](C)(CCC[C@]1([C@@H]3CC2)C)C(=O)O[C@H]1[C@@H]([C@@H](O)[C@H](O)[C@@H](CO)O1)O)[C@@H]1O[C@H](CO)[C@@H](O)[C@H](O)[C@H]1O HELXLJCILKEWJH-NCGAPWICSA-N 0.000 description 1
- 235000005493 rutin Nutrition 0.000 description 1
- IKGXIBQEEMLURG-BKUODXTLSA-N rutin Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](C)O[C@@H]1OC[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](OC=2C(C3=C(O)C=C(O)C=C3OC=2C=2C=C(O)C(O)=CC=2)=O)O1 IKGXIBQEEMLURG-BKUODXTLSA-N 0.000 description 1
- ALABRVAAKCSLSC-UHFFFAOYSA-N rutin Natural products CC1OC(OCC2OC(O)C(O)C(O)C2O)C(O)C(O)C1OC3=C(Oc4cc(O)cc(O)c4C3=O)c5ccc(O)c(O)c5 ALABRVAAKCSLSC-UHFFFAOYSA-N 0.000 description 1
- 229960004555 rutoside Drugs 0.000 description 1
- 229930182490 saponin Natural products 0.000 description 1
- 150000007949 saponins Chemical class 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 238000007789 sealing Methods 0.000 description 1
- 230000035807 sensation Effects 0.000 description 1
- 235000019615 sensations Nutrition 0.000 description 1
- 235000002639 sodium chloride Nutrition 0.000 description 1
- 235000014214 soft drink Nutrition 0.000 description 1
- 239000002904 solvent Substances 0.000 description 1
- 239000008107 starch Substances 0.000 description 1
- 235000019698 starch Nutrition 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003432 sterols Chemical class 0.000 description 1
- 235000003702 sterols Nutrition 0.000 description 1
- 239000000126 substance Substances 0.000 description 1
- 235000019408 sucralose Nutrition 0.000 description 1
- BAQAVOSOZGMPRM-QBMZZYIRSA-N sucralose Chemical compound O[C@@H]1[C@@H](O)[C@@H](Cl)[C@@H](CO)O[C@@H]1O[C@@]1(CCl)[C@@H](O)[C@H](O)[C@@H](CCl)O1 BAQAVOSOZGMPRM-QBMZZYIRSA-N 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 239000013589 supplement Substances 0.000 description 1
- 208000024891 symptom Diseases 0.000 description 1
- 235000010491 tara gum Nutrition 0.000 description 1
- 239000000213 tara gum Substances 0.000 description 1
- 239000011975 tartaric acid Substances 0.000 description 1
- 235000002906 tartaric acid Nutrition 0.000 description 1
- 239000000892 thaumatin Substances 0.000 description 1
- 235000010436 thaumatin Nutrition 0.000 description 1
- 229960003495 thiamine Drugs 0.000 description 1
- DPJRMOMPQZCRJU-UHFFFAOYSA-M thiamine hydrochloride Chemical compound Cl.[Cl-].CC1=C(CCO)SC=[N+]1CC1=CN=C(C)N=C1N DPJRMOMPQZCRJU-UHFFFAOYSA-M 0.000 description 1
- 235000015961 tonic Nutrition 0.000 description 1
- 230000001256 tonic effect Effects 0.000 description 1
- 229960000716 tonics Drugs 0.000 description 1
- 235000019607 umami taste sensations Nutrition 0.000 description 1
- 235000013311 vegetables Nutrition 0.000 description 1
- 235000010374 vitamin B1 Nutrition 0.000 description 1
- 239000011691 vitamin B1 Substances 0.000 description 1
- 235000019158 vitamin B6 Nutrition 0.000 description 1
- 239000011726 vitamin B6 Substances 0.000 description 1
- 229940011671 vitamin b6 Drugs 0.000 description 1
- 230000002618 waking effect Effects 0.000 description 1
- 229920001285 xanthan gum Polymers 0.000 description 1
- 235000010493 xanthan gum Nutrition 0.000 description 1
- 239000000230 xanthan gum Substances 0.000 description 1
- 229940082509 xanthan gum Drugs 0.000 description 1
- UHVMMEOXYDMDKI-JKYCWFKZSA-L zinc;1-(5-cyanopyridin-2-yl)-3-[(1s,2s)-2-(6-fluoro-2-hydroxy-3-propanoylphenyl)cyclopropyl]urea;diacetate Chemical compound [Zn+2].CC([O-])=O.CC([O-])=O.CCC(=O)C1=CC=C(F)C([C@H]2[C@H](C2)NC(=O)NC=2N=CC(=CC=2)C#N)=C1O UHVMMEOXYDMDKI-JKYCWFKZSA-L 0.000 description 1
Images
Landscapes
- Non-Alcoholic Beverages (AREA)
- Medicinal Preparation (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Medicines Containing Plant Substances (AREA)
Abstract
Description
本発明は、肝臓加水分解物に特有の不快臭及び雑味が低減された肝臓加水分解物含有液状組成物に関する。 The present invention relates to a liver hydrolyzate-containing liquid composition with reduced unpleasant odor and miscellaneous taste peculiar to liver hydrolyzate.
肝臓加水分解物は、ウシやブタなどの肝臓の加水分解物であり、肝臓機能を改善し、アルコール摂取時における体内のアセトアルデヒドの代謝を促進する作用を有することが知られている。そのため、肝臓加水分解物は、二日酔いの予防や軽減のほか、滋養強壮、貧血の改善、肌荒れの改善を目的とした医薬品や栄養補助剤(サプリメント)等に使用されており、特に日常的に手軽に摂取できるドリンク剤や内服液などの飲料形態で提供されている(特許文献1等)。しかしながら、肝臓加水分解物は、生物の肝臓を基原原料としていることから、肉特有の生臭み、焦げ感、旨味、後味の残り感があり、肝臓加水分解物を飲料に使用した場合には、これらの肝臓加水分解物に特有の不快臭や雑味が感じられて摂取しにくいという問題があった。 Liver hydrolyzate is a hydrolyzate of livers such as cattle and pigs, and is known to have an action of improving liver function and promoting metabolism of acetaldehyde in the body when ingesting alcohol. For this reason, liver hydrolysates are used in medicines and nutritional supplements (supplements) for the purpose of preventing and reducing hangovers, nutritional tonics, improving anemia, and rough skin. It is provided in the form of beverages such as drinks and internal liquids that can be ingested (Patent Document 1, etc.). However, since the liver hydrolyzate is based on the liver of the living organism, there is a raw odor, a burning sensation, a umami taste, and a feeling of aftertaste that is unique to meat. When liver hydrolyzate is used in beverages, However, there is a problem that unpleasant odor and miscellaneous taste peculiar to these liver hydrolysates are felt and it is difficult to take them.
肝臓加水分解物を含有する臓器製剤特有の不快な味と臭いを抑えるための手段として、L−アスパラギン酸ナトリウムおよびプラム系フレーバーもしくはシトラス系フレーバーを配合することが提案されているが(特許文献2)、その異質な風味のマスキング効果は十分ではなかった。また、特許文献3には、ウコンエキスを所定の比率で配合し、pHを所定範囲とすることで、肝臓加水分解物に特有の不快臭及び雑味を低減することが開示されている。
一方、ドクダミ(ジュウヤク)エキスは生薬成分として知られている(特許文献4等)。
As means for suppressing the unpleasant taste and odor peculiar to organ preparations containing liver hydrolysates, it has been proposed to blend sodium L-aspartate and plum or citrus flavors (Patent Document 2). ) The masking effect of the extraordinary flavor was not sufficient. Patent Document 3 discloses that an unpleasant odor and miscellaneous taste peculiar to liver hydrolyzate are reduced by blending turmeric extract at a predetermined ratio and adjusting the pH within a predetermined range.
On the other hand, dokudami (juyaku) extract is known as a herbal medicine component (Patent Document 4 etc.).
本発明の課題は、肝臓加水分解物の特有の不快臭及び雑味が低減され、摂取しやすい肝臓加水分解物含有液状組成物を提供することにある。 An object of the present invention is to provide a liver hydrolyzate-containing liquid composition that is reduced in the unpleasant odor and miscellaneous peculiarity of liver hydrolyzate and is easy to take.
本発明者らは上記課題を解決すべく鋭意研究を重ねた結果、肝臓加水分解物とドクダミエキスとを所定の比率で配合することにより、肝臓加水分解物の特有の不快臭及び雑味が低減され、摂取しやすい液状組成物を提供できることを見出し、本発明を完成するに至った。 As a result of intensive studies to solve the above-mentioned problems, the present inventors have reduced the unpleasant odor and miscellaneous taste peculiar to liver hydrolysates by blending liver hydrolyzate and dokudami extract in a predetermined ratio. The present inventors have found that a liquid composition that can be easily ingested can be provided, and have completed the present invention.
具体的には本発明は以下の発明を提供する。
(1)肝臓加水分解物とドクダミエキスとを、肝臓加水分解物100質量部に対して原生薬換算したドクダミエキスが21.7〜6500質量部の比で含有し、かつ、pHが4.0以下である肝臓加水分解物含有液状組成物。
(2)(1)に記載の液状組成物が入れられた、容器詰飲料。
(3)肝臓加水分解物とドクダミエキスとを、肝臓加水分解物100質量部に対して原生薬換算したドクダミエキスが21.7〜6500質量部の比となるように原料液に配合する工程を含む、pHが4.0以下である肝臓加水分解物含有液状組成物の製造方法。
(4)肝臓加水分解物を含有する原料液に、ドクダミエキスを、肝臓加水分解物100質量部に対して原生薬換算したドクダミエキスが21.7〜6500質量部の比となるように配合することによって、肝臓加水分解物含有液状組成物の不快臭及び雑味を低減する方法。
Specifically, the present invention provides the following inventions.
(1) A docami extract obtained by converting a liver hydrolyzate and a docami extract into a crude drug equivalent to 100 parts by mass of the liver hydrolyzate in a ratio of 21.7 to 6500 parts by mass, and a pH of 4.0. A liver hydrolyzate-containing liquid composition which is:
(2) A packaged beverage containing the liquid composition according to (1).
(3) The process which mix | blends a liver hydrolyzate and dokudami extract with a raw material liquid so that the ratio of 21.7-6500 mass parts of dokudami extract which converted the crude drug with respect to 100 mass parts of liver hydrolysates may be set. A method for producing a liver hydrolyzate-containing liquid composition having a pH of 4.0 or less.
(4) In the raw material liquid containing liver hydrolyzate, dokudami extract is blended so that the ratio of 21.7 to 6500 parts by weight of dokudami extract in terms of active ingredient is based on 100 parts by weight of liver hydrolyzate. The method of reducing the unpleasant odor and miscellaneous taste of a liquid composition containing a liver hydrolyzate.
本発明によれば、肝臓加水分解物に特有の不快臭及び雑味が低減され、摂取しやすい肝臓加水分解物含有液状組成物が提供される。 ADVANTAGE OF THE INVENTION According to this invention, the unpleasant odor and miscellaneous taste peculiar to a liver hydrolyzate are reduced, and the liver hydrolyzate containing liquid composition easy to ingest is provided.
1.肝臓加水分解物
本発明において肝臓加水分解物とは、ウシやブタなどの動物の肝臓を、消化酵素(タンパク質分解酵素)を用いて分解した分解生成物をいう。肝臓加水分解物は、肝臓水解物、肝臓エキスとも称され、本発明の肝臓加水分解物は、肝臓水解物、肝臓エキスと表記されるものを包含する概念である。
1. Liver hydrolyzate In the present invention, the liver hydrolyzate refers to a decomposition product obtained by decomposing the liver of an animal such as a cow or pig using a digestive enzyme (proteolytic enzyme). The liver hydrolyzate is also referred to as liver hydrolyzate or liver extract, and the liver hydrolyzate of the present invention is a concept including those expressed as liver hydrolyzate and liver extract.
2.ドクダミエキス
本発明においてドクダミエキスは、ドクダミから水溶性溶媒を用いて抽出し、加熱及び/又は減圧して抽出溶媒を揮発させることにより得ることができる。ここで用いる水溶性溶媒としては、アルコール等の水溶性有機溶媒や水が挙げられ、水と水溶性有機溶媒との混合溶媒でもよい。
2. Dokudami Extract In the present invention, the Dokudami Extract can be obtained by extracting water from a Dokudami using a water-soluble solvent and volatilizing the extraction solvent by heating and / or reducing pressure. Examples of the water-soluble solvent used here include water-soluble organic solvents such as alcohol and water, and a mixed solvent of water and a water-soluble organic solvent may be used.
3.肝臓加水分解物とドクダミエキスとの比
本発明の液状組成物における肝臓加水分解物とドクダミエキスの配合比は、肝臓加水分解物100質量部に対して、原生薬換算したドクダミエキスが21.7〜6500質量部であることが好ましく、50〜500質量部であることがより好ましく、50〜200質量部であることが特に好ましい。
3. Ratio of Liver Hydrolyzate and Dokudami Extract The mixing ratio of liver hydrolyzate and Dokudami extract in the liquid composition of the present invention was 21.7% of Dokudami Extract converted to the active ingredient with respect to 100 parts by mass of liver hydrolyzate. It is preferably ˜6500 parts by mass, more preferably 50 to 500 parts by mass, and particularly preferably 50 to 200 parts by mass.
肝臓加水分解物とドクダミエキスの配合比がこの範囲内であると、肝臓加水分解物に特有の不快臭及び雑味が感じられず、肝臓加水分解物含有液状組成物の風味や味を良好なものとすることができる。ここで、肝臓加水分解物に特有の不快臭及び雑味とは、肉特有の生臭み、肉特有の焦げ感、肉特有の旨味、肉特有の後味の残り感をいう。 When the blending ratio of the liver hydrolyzate and the Dokudami extract is within this range, the unpleasant odor and miscellaneous taste peculiar to the liver hydrolyzate are not felt, and the flavor and taste of the liver hydrolyzate-containing liquid composition are good. Can be. Here, the unpleasant odor and miscellaneous taste peculiar to the liver hydrolyzate refer to the raw odor peculiar to meat, the charcoal peculiar feeling of meat, the peculiar taste of meat, and the residual feeling of the aftertaste peculiar to meat.
また、本発明の液状組成物における肝臓加水分解物とドクダミエキスの配合量は、上記の配合比の範囲である限り特に限定はされない。例えば、肝臓加水分解物の配合量は、組成物全量に対し、0.01〜2.0質量%、好ましくは0.1〜1.0質量%が例示でき、ドクダミエキスの配合量は、肝臓加水分解物の配合量に対して上記の配合比となるように決定することができる。 Moreover, the compounding quantity of the liver hydrolyzate and a docami extract in the liquid composition of this invention will not be specifically limited as long as it is the range of said compounding ratio. For example, the compounding amount of the liver hydrolyzate can be exemplified by 0.01 to 2.0% by mass, preferably 0.1 to 1.0% by mass, with respect to the total amount of the composition, It can determine so that it may become said compounding ratio with respect to the compounding quantity of a hydrolyzate.
4.他の成分
本発明の液状組成物は、水に上記の肝臓加水分解物とドクダミエキスを配合するものであるが、一又は複数の他の成分を更に含有してもよい。他の成分は飲食品や医薬品などの最終的な形態において許容される成分であって、経口摂取可能な成分であれば特に限定はされないが、例えば、甘味料、環状オリゴ糖、酸味料、増粘剤、ビタミン類、香料、香辛料抽出物、酸化防止剤、乳化剤等が例示できる。
4). Other components Although the liquid composition of this invention mix | blends said liver hydrolyzate and a Dokudami extract in water, you may further contain one or several other components. The other components are components that are acceptable in the final form such as foods and drinks and pharmaceuticals, and are not particularly limited as long as they can be taken orally. For example, sweeteners, cyclic oligosaccharides, acidulants, Examples thereof include viscous agents, vitamins, fragrances, spice extracts, antioxidants, and emulsifiers.
甘味料としては、ショ糖、果糖、ブドウ糖、液糖、はちみつ等の糖類、スクラロース、アセスルファムカリウム、ソーマチン、アスパルテーム、ステビア等の高甘味度甘味料が挙げられる。 Examples of the sweetener include sugars such as sucrose, fructose, glucose, liquid sugar and honey, and high-intensity sweeteners such as sucralose, acesulfame potassium, thaumatin, aspartame and stevia.
酸味料としては、クエン酸の他に、リンゴ酸、グルコン酸、酒石酸、乳酸、リン酸、あるいはこれらの塩等が挙げられる。 Examples of the acidulant include malic acid, gluconic acid, tartaric acid, lactic acid, phosphoric acid, and salts thereof in addition to citric acid.
増粘剤としては、ジェランガム、発酵セルロース、キサンタンガム、アラビアガム、タマリンドガム、グアガム、ローカストビーンガム、カラヤガム、タラガム、寒天、ゼラチン、ペクチン、大豆多糖類、CMC(カルボキシメチルセルロース)、カラギナン、微結晶セルロース、アルギン酸プロピレングリコールエステル等が挙げられる。 Thickeners include gellan gum, fermented cellulose, xanthan gum, gum arabic, tamarind gum, guar gum, locust bean gum, karaya gum, tara gum, agar, gelatin, pectin, soy polysaccharide, CMC (carboxymethylcellulose), carrageenan, microcrystalline cellulose And alginic acid propylene glycol ester.
ビタミン類としては、ビタミンC、ビタミンB1、ビタミンB6,ビタミンE、ナイアシン、イノシトール等が挙げられる。 Examples of vitamins include vitamin C, vitamin B1, vitamin B6, vitamin E, niacin, inositol, and the like.
酸化防止剤としては、ビタミンC、ビタミンE、酵素処理ルチン、カテキン等が挙げられる。 Examples of the antioxidant include vitamin C, vitamin E, enzyme-treated rutin, catechin and the like.
乳化剤としては、グリセリン脂肪酸エステル、レシチン、植物性ステロール、サポニン等が挙げられる。 Examples of the emulsifier include glycerin fatty acid ester, lecithin, vegetable sterol, and saponin.
香辛料抽出物としては、ウコンエキス、ウコン色素等のウコン抽出物が例示できる。ウコンエキスは、ビサクロンを含有する水溶性ウコン抽出物を指す。ウコン色素は、クルクミノイドを含有する油溶性ウコン抽出物を指す。ウコンエキスとウコン色素とを合わせて用いてもよい。 Examples of the spice extract include turmeric extracts such as turmeric extract and turmeric pigment. Turmeric extract refers to a water-soluble turmeric extract containing bisaclone. Turmeric pigment refers to an oil-soluble turmeric extract containing curcuminoids. A turmeric extract and a turmeric pigment may be used in combination.
上記他の成分は、それぞれ当業者が飲料等の液状組成物に通常採用する範囲内の量で適宜配合することができる。 The above-mentioned other components can be appropriately blended in an amount within the range usually employed by those skilled in the art for liquid compositions such as beverages.
5.液状組成物のpH
本発明の液状組成物のpHはpH4.0以下が好ましい。本発明においてpH値は品温20℃で測定された値を指す。pH値が4.0よりも高い場合には肝臓加水分解物の特有の不快臭及び雑味の低減効果が得られないという問題がある。また、本発明の組成物が清涼飲料水の形態である場合には、当該pH値の上限をpH4.0未満とすることができる。pH値の下限は特に限定されず、2.3以上、好ましくは3.0以上、さらに好ましくは3.1以上とすることができる。
5. PH of liquid composition
The pH of the liquid composition of the present invention is preferably pH 4.0 or less. In the present invention, the pH value refers to a value measured at a product temperature of 20 ° C. When the pH value is higher than 4.0, there is a problem that the effect of reducing the unpleasant odor and miscellaneous taste peculiar to the liver hydrolyzate cannot be obtained. Moreover, when the composition of this invention is a form of a soft drink, the upper limit of the said pH value can be made into pH less than 4.0. The lower limit of the pH value is not particularly limited, and can be 2.3 or more, preferably 3.0 or more, and more preferably 3.1 or more.
本発明の組成物のpHの調整は、上記原料を混合し、必要に応じて適宜酸味料を加えることにより行う。酸味料としては、前記の一般的に使用される有機もしくは無機の食用酸またはそれらの塩を用いればよい。酸味料の使用量は、所望のpHとすることができ、かつ組成物の風味に影響がない範囲であれば特に限定されない。 Adjustment of pH of the composition of this invention is performed by mixing the said raw material and adding a sour agent suitably as needed. As the acidulant, the above-mentioned generally used organic or inorganic edible acids or salts thereof may be used. The amount of acidulant used is not particularly limited as long as it can be set to a desired pH and does not affect the flavor of the composition.
本発明の液状組成物は、液状食品(飲料)として提供されてもよいし、液状の経口投与用の医薬品(内服液)として提供されてもよいが、好ましくは飲料である。また、飲料は、嗜好性により、炭酸を含む炭酸飲料、ゲル化剤(デンプン、寒天、増粘剤等)を含むゼリー飲料としてもよい。 The liquid composition of the present invention may be provided as a liquid food (beverage) or a liquid pharmaceutical for oral administration (internal liquid), but is preferably a beverage. The beverage may be a carbonated beverage containing carbonic acid or a jelly beverage containing a gelling agent (starch, agar, thickener, etc.) depending on palatability.
6.液状組成物の製造方法
本発明の液状組成物は、水を基調とする組成物であり、上記の各成分を水と混合して製造することができる。本発明の液状組成物の製造方法は、肝臓加水分解物とドクダミエキスを最終的な液状組成物において上記比となるように原料液に配合する工程を少なくとも含んでいればよく、その他の工程は飲料の通常の製造方法に従う。各成分を配合した原料液は、必要によりpHを4.0以下に調整し、65〜100℃に加熱して殺菌処理を行い、飲料用容器に充填密封することにより加熱殺菌済みの殺菌された容器詰め液状組成物製品とすることができる。
6). Method for Producing Liquid Composition The liquid composition of the present invention is a composition based on water, and can be produced by mixing each of the above components with water. The method for producing the liquid composition of the present invention only needs to include at least a step of blending the liver hydrolyzate and the docami extract into the raw material liquid so as to have the above ratio in the final liquid composition. Follow the normal method for making beverages. The raw material liquid containing each component was adjusted to pH 4.0 or lower as necessary, sterilized by heating to 65 to 100 ° C., and sterilized by heat sterilization by filling and sealing in a beverage container. It can be set as a container-packed liquid composition product.
飲料用容器としては、ポリエチレンテレフタレート(PET)製容器、金属缶、金属箔やプラスチックフィルムと複合された紙容器、ガラス瓶が挙げられ、容器の形態は特に限定されない。また、容器の容量は特に限定されないが、例えば100ml〜500ml(典型的には100ml、150ml、200ml、250ml、300ml、350ml、400ml、450ml又は500ml)とすることができる。液状組成物を容器に収容する手段は任意である。 Examples of the beverage container include a polyethylene terephthalate (PET) container, a metal can, a paper container combined with a metal foil or a plastic film, and a glass bottle, and the form of the container is not particularly limited. The capacity of the container is not particularly limited, but can be, for example, 100 ml to 500 ml (typically 100 ml, 150 ml, 200 ml, 250 ml, 300 ml, 350 ml, 400 ml, 450 ml or 500 ml). The means for accommodating the liquid composition in the container is arbitrary.
本発明の液状組成物は肝臓加水分解物特有の不快臭及び雑味が低減された肝臓加水分解物含有組成物である。本発明の液状組成物は、例えば、アルコール摂取後の起床時のいわゆる二日酔い症状(特に、頭重感、アルコール残り感、胃の不快症状)の軽減作用を有する飲食品組成物や医薬品組成物として使用できる。 The liquid composition of the present invention is a liver hydrolyzate-containing composition with reduced unpleasant odor and miscellaneous taste peculiar to liver hydrolysates. The liquid composition of the present invention is used, for example, as a food / beverage composition or a pharmaceutical composition having an action to reduce so-called hangover symptoms (particularly, head sensation, feeling of residual alcohol, stomach discomfort) upon waking up after alcohol consumption it can.
以下、実施例によって本発明を更に具体的に説明するが、これらの実施例は本発明を限定するものでない。 EXAMPLES Hereinafter, the present invention will be described more specifically with reference to examples, but these examples do not limit the present invention.
1.試験飲料の調製
各試験飲料は、表1、2に示す配合量にて、水以外の成分(粉末原料)を混合した後、水に添加溶解して、液体原料を投入して全量100gの水溶液とした。各試験飲料のpHはクエン酸にて調整した。表中のpH値は品温20℃で測定された値を示す。表中の各成分の単位は質量(g)である。
1. Preparation of test beverages Each test beverage was mixed with ingredients other than water (powder raw material) in the blending amounts shown in Tables 1 and 2, and then added and dissolved in water. It was. The pH of each test beverage was adjusted with citric acid. The pH value in the table indicates a value measured at a product temperature of 20 ° C. The unit of each component in the table is mass (g).
本試験で使用したドクダミエキスは、ドクダミエキス1kgあたり原生薬(ドクダミ乾燥物)6.5kgから製造されたものである。 The dokudami extract used in this test was produced from 6.5 kg of the crude drug (dried dokudami) per kg of dokudami extract.
2.試験(官能評価)方法
試験は、20歳以上50歳以下の健常な男女7名をパネラーとして選定し、官能評価を行なった。パネラーは各試験飲料を摂取し、「肉特有の生臭み」、「肉特有の焦げ感」、「肉特有の旨味」、「肉特有の後味の残り感」の項目について0〜10段階(0:弱い、10:強い)での評価を行なった。なお、結果は、各試験飲料におけるパネラー評価の平均値を示した。
2. Test (Sensory Evaluation) Method In the test, seven healthy men and women aged 20 to 50 were selected as panelists to perform sensory evaluation. The panelist ingested each test beverage, and 0 to 10 levels (0 for the items of “meat-specific odor”, “meat-specific scorch”, “meat-specific umami”, “meat-specific aftertaste”) : Weak, 10: strong). In addition, the result showed the average value of the paneler evaluation in each test drink.
3.官能試験結果
3.1.肝臓加水分解物とドクダミエキス(原生薬換算)の配合比
実施例1(肝臓加水分解物:ドクダミエキス(原生薬換算)=1:65(pH3.6)、実施例2(肝臓加水分解物:ドクダミエキス(原生薬換算)=30:6.5、pH3.6)、実施例3(肝臓加水分解物:ドクダミエキス(原生薬換算)=12:6.5、pH3.6)、および実施例4(肝臓加水分解物:ドクダミエキス(原生薬換算)=6:6.5、pH3.6)、実施例5(肝臓加水分解物:ドクダミエキス(原生薬換算)=3:6.5、pH3.6)の試験飲料のパネラーによる官能評価試験の結果をそれぞれ図1、図2、図3、図4、図5に示す。各実施例の結果は、同量の肝臓加水分解物を配合し、ドクダミエキスは含まない試験飲料(比較例1、2)と比較し、同じ図に示した。図1〜5に示すように、肝臓加水分解物とともにドクダミエキスを配合した試験飲料(実施例1〜5)では、いずれも肝臓加水分解物特有の生臭み・焦げ感・旨味・後味の残り感が低減され、肝臓加水分解物特有の異質な風味が改善された。これらの結果から、肝臓加水分解物とドクダミエキス(原生薬換算)の含有比が質量比で1:65〜30:6.5である場合に効果があるといえる。
3. Sensory test results 3.1. Mixing ratio of liver hydrolyzate and dokudami extract (raw substance conversion) Example 1 (liver hydrolyzate: dokudami extract (raw drug conversion) = 1: 65 (pH 3.6), Example 2 (liver hydrolyzate: Docami extract (converted as crude drug) = 30: 6.5, pH 3.6), Example 3 (liver hydrolyzate: docami extract (converted as drug substance) = 12: 6.5, pH 3.6), and Examples 4 (liver hydrolyzate: dokudami extract (in terms of drug substance) = 6: 6.5, pH 3.6), Example 5 (liver hydrolyzate: dokudami extract (in terms of drug substance)) = 3: 6.5, pH 3 The results of sensory evaluation tests by panelists of test drinks of 6) are shown in Fig. 1, Fig. 2, Fig. 3, Fig. 4 and Fig. 5. The results of each example are the same amount of liver hydrolyzate. , Compared with the test beverages (Comparative Examples 1 and 2) that do not contain the Dokudami extract, As shown in FIGS. 1 to 5, in the test beverages (Examples 1 to 5) in which the docomami extract was blended with the liver hydrolyzate, all of the live smell, scorch, The remaining taste of umami and aftertaste was reduced, and the unusual flavor unique to liver hydrolyzate was improved.From these results, the content ratio of liver hydrolyzate and dokudami extract (in terms of crude drug) is 1: It can be said that it is effective when it is 65-30: 6.5.
3.2.pHの範囲
実施例6(肝臓加水分解物:ドクダミエキス(原生薬換算)=6:6.5、pH3.0)、実施例7(肝臓加水分解物:ドクダミエキス(原生薬換算)=6:6.5、pH4.0)の試験飲料のパネラーによる官能評価試験の結果を図6に示す。各実施例の結果は、同量の肝臓加水分解物を配合し、ドクダミエキスは含まない試験飲料(比較例2)と比較し、同じ図に示した。図6に示すように、肝臓加水分解物とともにドクダミエキスを配合し、かつpHを3.0または4.0に調整した試験飲料(実施例6、7)では、いずれも肝臓加水分解物特有の生臭み・焦げ感・旨味・後味の残り感が低減され、肝臓加水分解物特有の異質な風味が改善された。これらの結果と前記実施例1〜5の結果を合わせると、pHが4.0以下である場合に効果があるといえる。
3.2. Range of pH Example 6 (liver hydrolyzate: dokudami extract (concentration of crude drug) = 6: 6.5, pH 3.0), Example 7 (liver hydrolyzate: dokudami extract (concentration of drug substance) = 6: The result of the sensory evaluation test by the panel of the test drink of 6.5, pH 4.0) is shown in FIG. The result of each Example was shown in the same figure compared with the test drink (comparative example 2) which mix | blended the same amount of liver hydrolyzate and does not contain a docami extract. As shown in FIG. 6, in the test beverages (Examples 6 and 7) in which the docami extract was blended with the liver hydrolyzate and the pH was adjusted to 3.0 or 4.0, both were specific to the liver hydrolyzate. The raw odor, burning, umami, and aftertaste are reduced, and the unusual flavor unique to liver hydrolysates is improved. When these results and the results of Examples 1 to 5 are combined, it can be said that there is an effect when the pH is 4.0 or less.
3.3.他のマスキング剤の効果
ドクダミエキスと同様に苦味のある、グレープフルーツフレーバー(ナリンギン13〜15.5%含有)、テンチャエキス、マッチャエキスの効果を試験した。比較例3(肝臓加水分解物:グレープフルーツフレーバー=0.6:0.1、pH3.6)、比較例4(肝臓加水分解物:テンチャエキス=0.6:1.5、pH3.6)、比較例5(肝臓加水分解物:マッチャエキス=0.6:0.15の試験飲料のパネラーによる官能評価試験の結果を図7に示す。各試験の結果は、同量の肝臓加水分解物のみを含む試験飲料(比較例2)と比較した。図7に示すように、肝臓加水分解物特有の生臭み・焦げ感・後味の残り感を低減し、肝臓加水分解物特有の異質な風味を改善する効果が認められるのはドクダミエキスだという結果が得られた。これらの結果より、単なる苦味成分を配合するだけでは肝臓加水分解物の異質な風味をマスキングできないといえる。
3.3. Effects of other masking agents The effects of grapefruit flavor (containing 13 to 15.5% naringin), tencha extract, and matcher extract having a bitter taste similar to those of docami extract were tested. Comparative Example 3 (liver hydrolyzate: grapefruit flavor = 0.6: 0.1, pH 3.6), Comparative Example 4 (liver hydrolyzate: tencha extract = 0.6: 1.5, pH 3.6), The result of the sensory evaluation test by the panelist of the test drink of Comparative Example 5 (liver hydrolyzate: matcher extract = 0.6: 0.15 is shown in FIG. 7. The result of each test is the same amount of liver hydrolyzate only. As shown in Fig. 7, it reduces the raw smell, burnt feeling and residual feeling of the aftertaste peculiar to the liver hydrolyzate, and has the extraordinary flavor peculiar to the liver hydrolyzate. The results showed that the effect of improvement was found to be the dokudami extract, and it can be said from these results that it is not possible to mask the heterogeneous flavor of the liver hydrolyzate by simply adding a bitter component.
4.飲料の配合例
本発明の飲料組成物の具体的な配合の一例を表3に示す。
水以外の成分(粉末原料)を混合した後、水に添加溶解して、液体原料を投入して全量100gの水溶液とした。表中の各成分の単位は質量(g)である。
4). Table 3 shows an example of a specific formulation of the beverage composition of the present invention.
Components other than water (powder raw material) were mixed, then added and dissolved in water, and the liquid raw material was added to make a total amount of 100 g of an aqueous solution. The unit of each component in the table is mass (g).
本発明によれば、肝臓加水分解物に特有の不快臭及び雑味が低減され、摂取しやすい肝臓加水分解物含有液状組成物が提供される。従って、本発明は、飲料や内服液の製造分野において利用できる。 ADVANTAGE OF THE INVENTION According to this invention, the unpleasant odor and miscellaneous taste peculiar to a liver hydrolyzate are reduced, and the liver hydrolyzate containing liquid composition easy to ingest is provided. Therefore, this invention can be utilized in the manufacture field | area of a drink or an internal use liquid.
Claims (4)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017106825A JP6849281B2 (en) | 2017-05-30 | 2017-05-30 | Composition containing liver hydrolyzate and Houttuynia cordata extract |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2017106825A JP6849281B2 (en) | 2017-05-30 | 2017-05-30 | Composition containing liver hydrolyzate and Houttuynia cordata extract |
Publications (2)
Publication Number | Publication Date |
---|---|
JP2018201345A true JP2018201345A (en) | 2018-12-27 |
JP6849281B2 JP6849281B2 (en) | 2021-03-24 |
Family
ID=64954188
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP2017106825A Active JP6849281B2 (en) | 2017-05-30 | 2017-05-30 | Composition containing liver hydrolyzate and Houttuynia cordata extract |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP6849281B2 (en) |
Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015091768A (en) * | 2013-09-30 | 2015-05-14 | ハウス食品グループ本社株式会社 | Liver hydrolysate-containing liquid composition |
JP2016216441A (en) * | 2015-05-20 | 2016-12-22 | ゼリア新薬工業株式会社 | Liquid agent for internal use |
-
2017
- 2017-05-30 JP JP2017106825A patent/JP6849281B2/en active Active
Patent Citations (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JP2015091768A (en) * | 2013-09-30 | 2015-05-14 | ハウス食品グループ本社株式会社 | Liver hydrolysate-containing liquid composition |
JP2016216441A (en) * | 2015-05-20 | 2016-12-22 | ゼリア新薬工業株式会社 | Liquid agent for internal use |
Also Published As
Publication number | Publication date |
---|---|
JP6849281B2 (en) | 2021-03-24 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP5595614B1 (en) | Liver hydrolyzate-containing liquid composition | |
US20090169682A1 (en) | Functional Masticatory Material, Method Of Producing The Same And Method Of Using The Same | |
KR101367741B1 (en) | Compositions comprising garcinia cambogia extract and methods for preparing the same | |
CN106061479B (en) | Weak prophylactic | |
CN105211481A (en) | Tasty and refreshing sugar of a kind of agate card prebiotics sugar-free and preparation method thereof | |
JP5921143B2 (en) | Flavor improving agent for beverages containing ginger | |
JP2020150953A (en) | Beverage | |
CN112120221A (en) | High calorie nutritional composition | |
JP2015173631A (en) | Packed carbonated beverage containing star anise extract | |
JP2010063390A (en) | Food and drink | |
JP5355809B1 (en) | Beverage | |
JP2015063520A (en) | Salivary secretion promoter | |
JP6849281B2 (en) | Composition containing liver hydrolyzate and Houttuynia cordata extract | |
JP6840647B2 (en) | Liquid composition, its cloudiness improving agent, odor improving agent, and manufacturing method | |
JP6161595B2 (en) | Beverage | |
JPH10179077A (en) | Bitter taste masking agent | |
JP6686292B2 (en) | Amino acid-containing composition | |
JP7336970B2 (en) | Paffia-containing acidic food and drink | |
JP5998351B2 (en) | Composition for preventing or improving snoring | |
JP2011231051A (en) | Oral jelly preparation containing vitamin b1 | |
JP6178196B2 (en) | Alanine-containing liquid composition | |
JP2017193532A (en) | Composition for improving bone density, food composition for improving bone density, composition for improving liver function, and food composition for improving liver function | |
JP6758619B2 (en) | Composition | |
JP6261263B2 (en) | Turmeric extract-containing beverage | |
JP2019198233A (en) | Qol improving or maintaining agent on mental aspect |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
A625 | Written request for application examination (by other person) |
Free format text: JAPANESE INTERMEDIATE CODE: A625 Effective date: 20200219 |
|
A977 | Report on retrieval |
Free format text: JAPANESE INTERMEDIATE CODE: A971007 Effective date: 20201224 |
|
TRDD | Decision of grant or rejection written | ||
A01 | Written decision to grant a patent or to grant a registration (utility model) |
Free format text: JAPANESE INTERMEDIATE CODE: A01 Effective date: 20210202 |
|
A61 | First payment of annual fees (during grant procedure) |
Free format text: JAPANESE INTERMEDIATE CODE: A61 Effective date: 20210302 |
|
R150 | Certificate of patent or registration of utility model |
Ref document number: 6849281 Country of ref document: JP Free format text: JAPANESE INTERMEDIATE CODE: R150 |
|
R250 | Receipt of annual fees |
Free format text: JAPANESE INTERMEDIATE CODE: R250 |